Evidence map›Paper›PMID 35692969›Full record

ArticleAnnals of medicine and surgery (2012)2022

Emergence of Omicron BA.1 and BA.2 variants and concern over vaccine breakthrough infection.

Mahnoor Sukaina, Mohammad Mehedi Hasan, Mohammad Yasir Essar

Abstract read
In one paragraph

Article in Annals of medicine and surgery (2012), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mahnoor SukainaKarachi Medical and Dental College, Karachi, Pakistan.
Mohammad Mehedi HasanDepartment of Biochemistry and Molecular Biology, Faculty of Life Science, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh.
Mohammad Yasir EssarAfghanistan National Charity Organization for Special Diseases (ANCOSD), Kabul, Afghanistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic since 2020 created havoc across the globe. This led to the establishment of effective vaccines to mitigate the virus. Several vaccines are developed to create immunity amongst the population. However, due to emerging variants of SARS-CoV-2, despite a double dose of vaccines, people have still infected that termed vaccine breakthrough infection. This paper aims to highlight the recent re-surging massive outbreak of COVID-19 in China despite mass vaccination and, discuss the issue of vaccine breakthrough infection, possible causes, and recommendations to enhance immunity and curb the transmission.

Indexed as

BA.1 variantBA.2 variantCOVID-19Fourth recommended COVID-19 vaccineRecommendation third booster doseSARS-CoV-2Vaccine breakthrough infection

Identifiers

PMID35692969
PMCPMC9167681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.